Skip to main content

Explore our articles, audio-visual presentations, and scientific insights

Our scientific teams are committed to thought leadership and we regularly develop insights, webinars, and conference presentations to support knowledge-sharing within the industry. Contact us with any questions or to request slide decks.

blog insights

Audio-visual presentations

How Genesis Research Group 'Innovates differently'

NEW POST: May 2024
Our new CEO David W. Miller explains what we mean when we say we help our life science clients to ‘Innovate differently’ and transform the way they engage with research partners.

Envision Analogue - an introduction

NEW POST: April 2024
An interview with Executive Director Tijana Ignjatovic regarding Envision, a platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive EMA or FDA guidance. Download our Envision brochure.

Shining the light on vaccine market access

NEW POST: April 2024
In March 2024, Genesis Research Group’s Katrin Nather and Tijana Ignjatovic presented at the World EPA Congress 2024 on the subject of ‘Shining the light on vaccine market access’. Discover our RPR-powered access and pricing capabilities.

An introduction to the Flexible Integrated Team (FIT) engagement model

Our unique Flexible Integrated Team (FIT) engagement model represents a paradigm shift in how companies engage with a pharmaceutical, biotech and medical device research partners. Find out more.

Fit-for-purpose matchmaking

Our webinar ‘Fit-for-purpose matchmaking: a data selection and RWE approach for both regulatory and HTA audiences’ was held in February 2024 with Allie Sosinsky, Director, Pharmacoepidemiology and Safety, and Carole Longson MBE, Professor and Independent Senior Advisor. Explore our RWE expertise.

External control arms for regulatory and HTA agencies

In May 2023, Jen Wogen and Craig S. Parzynski presented at ISPOR 23 on ‘Developing Fit-for-Purpose External Control Arms to Optimize Submissions to Regulatory and Health Technology Assessment Agencies.’ Discover our ECA and RWE capabilities.

Accelerating the generation of payer insights and evidence

Priti Jhingran and Tijana Ignjatovic present a webinar describing how actionable payer insights facilitate an informed approach to evidence generation that is meaningful to payer, HTA, and medical decision-makers. Read more about RPR.

An introduction to our stakeholder engagement platform

RPR provides robust, transparent, survey-based stakeholder engagement in a fraction of the time and cost of traditional methods, plus the ability to ask participants clarificatory and follow-up questions. Read about RPR.

Stakeholder validation of evidence generation plans

At the World EPA Congress in March 2023, VP, Evidence Strategy Priti Jhingran delivered a presentation on ‘Stakeholder Validation of Evidence Generation Plans (EGPs) to Achieve Optimal Access’. Read more about stakeholder insights.

Request slide decks or ask our RWE, HEOR, or market access experts a question

Get in touch


Sign up to receive regular thought leadership articles and videos, plus the latest RWE, HEOR, and market access trends

Sign up for our Newsletter


111 River Street, Suite 1120
Hoboken, New Jersey 07030, US